Monte Rosa Therapeutics I... (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

4.96

0.06 (1.22%)

At close: May 02, 2025, 3:59 PM

4.97

0.30%

After-hours: May 02, 2025, 04:05 PM EDT

Monte Rosa Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-72.7M	-135.35M	-108.5M	-73.96M	-35.88M	-7.74M
Depreciation & Amortization	8.12M	6.22M	3.75M	2.13M	537K	72K
Stock-Based Compensation	18.13M	16.67M	11.66M	5.2M	354K	n/a
Other Working Capital	84.81M	64.81M	-1.39M	6.99M	820K	-1.09M
Other Non-Cash Items	-2.95M	-3.81M	2.76M	960K	7.68M	-276K
Deferred Income Tax	n/a	n/a	n/a	17K	n/a	n/a
Change in Working Capital	91.4M	72.47M	-2.13M	6.29M	4.25M	1.77M
Operating Cash Flow	42M	-43.8M	-92.47M	-59.36M	-23.05M	-6.17M
Capital Expenditures	-3.99M	-19.04M	-12.91M	-9.73M	-3.39M	-1.39M
Cash Acquisitions	n/a	n/a	109K	79K	n/a	n/a
Purchase of Investments	-230.36M	-103.15M	-384.42M	n/a	n/a	n/a
Sales Maturities Of Investments	189.9M	210.93M	178M	n/a	n/a	n/a
Other Investing Acitivies	n/a	62K	-206.31K	79.00	n/a	n/a
Investing Cash Flow	-44.45M	88.8M	-219.22M	-9.65M	-3.39M	-1.39M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	750K
Common Stock Repurchased	-641K	n/a	n/a	n/a	-440K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	98.59M	27.49M	411K	-3.19M	n/a	n/a
Financial Cash Flow	98.89M	27.49M	20.47M	377.56M	60.06M	15M
Net Cash Flow	96.44M	72.49M	-291.22M	308.55M	33.62M	7.44M
Free Cash Flow	38.01M	-62.84M	-105.38M	-69.09M	-26.44M	-7.56M